TipRanks
Go Ultimate55% OFF

ConvaTec (2CV) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

2CV Analyst Ratings

Strong Buy
10Ratings
10Buy0Hold0Sell
Based on 10 analysts giving stock ratings to ConvaTec in the past 3 months

2CV Stock 12 Month Forecast

EUR 3.71▲(26.30% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for ConvaTec in the last 3 months. The average price target is EUR 3.71 with a high forecast of EUR 4.47 and a low forecast of EUR 3.22. The average price target represents a 26.30% change from the last price of EUR 2.94.
Highest Price TargetEUR 4.47Average Price TargetEUR 3.71Lowest Price TargetEUR 3.22

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:2CV
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
BarclaysEUR 3.58buy21.68%UpsideReiterated10/01/26
Berenberg Bank Analyst forecast on DE:2CVUnknown AnalystNot RankedBerenberg BankEUR 4.05→EUR 3.99buy35.87%UpsideReiterated09/10/26
Morgan StanleyEUR 3.14→EUR 3.45buy17.22%UpsideReiterated09/02/26
UBSEUR 4.47buy52.10%UpsideReiterated08/06/26
Goldman SachsEUR 3.46→EUR 3.58buy21.68%UpsideReiterated08/05/26
Deutsche Bank  Analyst forecast on DE:2CVUnknown AnalystNot RankedDeutsche Bank EUR 3.76buy27.76%UpsideReiterated08/05/26
JefferiesEUR 3.58buy21.68%UpsideReiterated08/05/26
Stifel NicolausEUR 3.76buy27.76%UpsideReiterated08/04/26
Peel Hunt Analyst forecast on DE:2CVUnknown AnalystNot RankedPeel HuntEUR 3.22buy9.51%UpsideReiterated08/04/26
RBC CapitalEUR 3.76buy27.76%UpsideReiterated08/02/26
J.P. MorganEUR 3.66→EUR 3.51buy19.24%UpsideReiterated05/22/26
CitiEUR 2.98→EUR 2.74hold-6.71%DownsideReiterated05/18/26
Panmure LiberumEUR 3.70buy25.73%UpsideReiterated02/24/26
BernsteinEUR 3.52buy19.65%UpsideInitiated01/28/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ConvaTec

3 Months
Success Rate11/18 ratings generated profit
61%
Average Return
+2.46%

Copying Graham Doyle's trades and holding each position for 3 Months would result in 61.11% of your transactions generating a profit, with an average return of +2.46% per trade.

1 Year
Sam England
Sam EnglandBerenberg Bank
Success Rate11/13 ratings generated profit
85%
Average Return
+4.22%

Copying Sam England's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +4.22% per trade.

2 Years
Sam England
Sam EnglandBerenberg Bank
Success Rate10/13 ratings generated profit
77%
Average Return
+10.25%

Copying Sam England's trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +10.25% per trade.

2CV Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 2CV
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy55122
Buy1161199
Hold11000
Sell00000
Strong Sell00000
total1712121111

In the current month, 2CV has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2CV average Analyst price target in the past 3 months is 3.71.

2CV Financial Forecast

EUR -1EUR -0.5EUR 0EUR 0.5EUR 1Q2 2025Q2 2026Q4 2026
HighEUR 0.11
ConsensusEUR 0.10
LowEUR 0.10

2CV Earnings Forecast

Next quarter’s earnings estimate for 2CV is EUR 0.10 with a range of EUR 0.10 to EUR 0.11. The previous quarter’s EPS was EUR 0.08. 2CV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2CV has Performed in-line its overall industry.

EUR 1.1BEUR 1.1BEUR 1.1BEUR 1.2BEUR 1.2BQ2 2025Q2 2026Q4 2026
HighEUR 1.2B
ConsensusEUR 1.19B
LowEUR 1.18B

2CV Sales Forecast

Next quarter’s sales forecast for 2CV is EUR 1.19B with a range of EUR 1.18B to EUR 1.20B. The previous quarter’s sales results were EUR 1.08B. 2CV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2CV has Performed in-line its overall industry.

2CV Stock Forecast FAQ

What is DE:2CV’s average 12-month price target, according to analysts?
Based on analyst ratings, ConvaTec’s 12-month average price target is €3.71.
What is DE:2CV’s upside potential, based on the analysts’ average price target?
ConvaTec has 26.30% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ConvaTec a Buy, Sell or Hold?
ConvaTec has a consensus rating of Strong Buy, which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.
What is ConvaTec’s share price target?
The average share price target for ConvaTec is €3.71. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €4.47, and the lowest forecast is €3.22. The average share price target represents a 26.30% increase from the current price of €2.94.
What do analysts say about ConvaTec?
ConvaTec’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of ConvaTec?
To buy shares of DE:2CV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.